Skip to main content

Result releasedAnnolyse analysis published

Iperion's preliminary loss widened after manufacturing expenditure

Exact source statement comparison; reported operating, profit and cash-flow bases retained.

IPR revenue trajectory

Revenue context before the current result.

Loading chart...
FY24 was $0m, versus $0m in FY23.

IPR operating cash flow

Operating cash flow across covered periods.

Loading chart...
FY24 was -$0.73m, versus -$0.41m in FY23.

IPR NPAT trajectory

Statutory profit after tax across covered periods.

Loading chart...
FY24 was -$0.8m, versus -$0.3m in FY23.

IPR ROE

Return on equity across covered periods.

Loading chart...
FY24 was -99.8%, versus -17.2% in FY23.

Market context

Valuation

These ratios pair a market close from around the result date with verified filing data. An unavailable metric means the required inputs were missing or unsuitable for comparison.

Prices as at close, 20 November 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$1.5m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

Not available

i

Not meaningful when recent earnings are negative.

EPS

-0.00

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

Not available

i

Not meaningful when recent EBITDA is negative.

P/FCF

Not available

i

Not meaningful when free cash flow is negative or unavailable.

P/B

28.61x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

0.0%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
29 May 2024
Published
23 October 2026

Key metrics

Numbers worth scanning first

FY24 vs FY23

Revenue

$0m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

EBITDA

−$0.8m

-186.8% ↓ vs −$0.28m

Net profit after tax

−$0.8m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net cash inflow from operating activities

−$0.73m

-77.7% ↓ vs −$0.41m

Profit before tax

−$0.8m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Cash and cash equivalents

$0.17m

-55.8% ↓ vs $0.38m

Total assets

$0.9m

-48.3% ↓ vs $1.7m

Analysis ofIPR FY24Result releasedAnnolyse analysis published

What changed

Iperion, formerly Southern Charter Financial Group, reported a preliminary loss of NZ$812,259 for the year ended 31 March 2024, compared with NZ$280,107 in FY23

The NZX form reports no revenue; the income statement separately reports interest income of NZ$41,396, compared with NZ$26,121.

← Swipe to view more
Briefing data table
NZ$ FY24 FY23
Deposit interest income 41,396 26,121
Administrative expenses 344,372 306,197
Outsourced manufacturing plant expenses 500,000 —
Loss before tax and net loss n/m n/m

What matters

The statement records NZ$500,000 of outsourced manufacturing plant expenses, alongside higher administration costs

The increase in interest income only partly offsets those expenses. Depreciation, amortisation and impairment of NZ$9,283 sits below the statement's NZ$802,976 loss-before-interest subtotal; the NZ$41,396 interest income is already included above that subtotal and must not be added again.

Assets fell to NZ$898,511 from NZ$1,737,758. Equity was NZ$814,081, compared with NZ$1,626,340. Cash and cash equivalents were NZ$168,647 and term deposits NZ$691,074; those are separate balances.

Expectations

The directors describe a focus on sales and marketing and converting product trials into longer-term agreements

Their stated licence targets are five Pathoglaze customers and at least SGD150,000 of revenue in the twelve months to September 2025, increasing to SGD1,000,000 by September 2026. These are targets, not sales demonstrated by this preliminary result.

Quality of result

Operating cash outflow was NZ$724,920, compared with NZ$407,825

Maturing term deposits provided NZ$520,737, partly offset by NZ$9,284 of intangible purchases, leaving NZ$511,453 of investing inflow. Cash fell by NZ$213,467. A deposit maturity changes the form of liquid assets; it is not operating revenue.

The statements are preliminary and unaudited. The NZX form says the company does not propose a dividend.

Unresolved

Open questions

What customer agreements support the stated licence targets?
How much further production and marketing expenditure is required before the business produces operating cash?
How will management fund the next phase if operating cash outflows continue?

This briefing cannot assess future customer conversions, licence-target delivery or funding availability from these preliminary statements.

Ask about IPR FY24

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Iperion's FY24 result.

What customer agreements support the stated licence targets?Why does "The statement records NZ$500,000 of outsourced manufacturing plant expenses, alongside higher administration costs" matter?How strong was the cash and earnings quality in FY24?What should I watch next for IPR after FY24?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Iperion: exact FY24 statement column

FY24 / financial report

Prior comparable period

Iperion: exact FY23 statement column

FY23 / financial report

Related insights

Compare this result's metrics with other covered NZX companies.

Get notified when IPR publishes next

Get the next Iperion briefing and related NZX reporting-season updates by email.